Type of security: Stock
Sector: Health Care
Industry: Medical/Nursing Services
The data is delayed by 15 minutes.
Description: Amedisys, Inc., together with its subsidiaries, provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The Home Health segment offers a range of services in the homes of individuals who may be recovering from an illness, injury, or surgery. This segment provides skilled nurses, nurse practitioners, home health aides, physical and occupational therapists, speech therapists, and medical social services; and chronic care clinical programs for patients with chronic diseases, such as cardiovascular, respiratory, diabetes, behavioral health, rehabilitative, and medical surgical conditions. The Hospice segment offers care that is designed to provide comfort and support for those who are facing a terminal illness, including heart disease, pulmonary disease, dementia, Alzheimer?s, HIV/AIDS, or cancer. As of December 31, 2013, it owned and operated 367 Medicare-certified home health care centers, 97 Medicare-certified hospice care centers, and 1 hospice inpatient unit
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||Sales Growth - Q/Q||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||ROE||ROI|
|Current Ratio||Quick Ratio||Long Term Debt/Equity||Debt Ratio|
|Gross Margin||Operating Margin||Net Profit Margin||Dividend Payout Ratio|
|Cash From Financing Activities||-20.05 M||Cash From Investing Activities||-11.82 M||Cash From Operating Activities||57.04 M||Gross Profit||138.45 M|
|Net Profit||10.64 M||Operating Profit||15.53 M||Total Assets||645.43 M||Total Current Assets||168.37 M|
|Total Current Liabilities||176.03 M||Total Debt||95.52 M||Total Liabilities||266.09 M||Total Revenue||314.15 M|
|High 52 week||140.23||Low 52 week||55.03||Last close||126.89||Last change||-1.51%|
|RSI||36||Average true range||4.48||Beta||0.82||Volume||144.91 K|
|Simple moving average 20 days||-4.02%||Simple moving average 50 days||1.67%||Simple moving average 200 days||15.2%|
|Performance Week||-6.85%||Performance Month||-0.74%||Performance Quart||8.6%||Performance Half||4.14%|
|Performance Year||122.54%||Performance Year-to-date||8.35%||Volatility daily||1.97%||Volatility weekly||4.41%|
|Volatility monthly||9.05%||Volatility yearly||31.34%||Relative Volume||270.73%||Average Volume||497.76 K|
|New High||New Low|
2019-06-24 09:00:01 | Amedisys AMED Upgraded to Strong Buy: Here's What You Should Know
2019-06-21 11:55:03 | Top Ranked Momentum Stocks to Buy for June 21st
2019-06-20 07:42:11 | Bet Big on DuPont Analysis With These Top 5 Picks
2019-06-19 10:53:53 | Here’s What Hedge Funds Think About Amedisys Inc AMED
2019-06-17 08:45:12 | Here is Why Growth Investors Should Buy Amedisys AMED Now
2019-06-14 08:11:47 | I Ran A Stock Scan For Earnings Growth And Amedisys NASDAQ:AMED Passed With Ease
2019-06-13 08:45:12 | 5 Stocks With Impressive Interest Coverage Ratio to Buy Now
2019-06-11 08:04:23 | See what the IHS Markit Score report has to say about Amedisys Inc.
2019-06-10 08:04:08 | See what the IHS Markit Score report has to say about Amedisys Inc.
2019-06-08 08:06:51 | See what the IHS Markit Score report has to say about Amedisys Inc.
2019-06-04 08:01:54 | See what the IHS Markit Score report has to say about Amedisys Inc.
2019-05-31 11:38:03 | Zacks.com featured highlights include: Shoe Carnival, Ulta, Amedisys, NVR and EMCOR
2019-05-31 08:45:12 | 3 Reasons Why Growth Investors Shouldn't Overlook Amedisys AMED
2019-05-30 09:31:01 | Amedisys AMED Down 9.3% Since Last Earnings Report: Can It Rebound?
2019-05-30 08:03:48 | See what the IHS Markit Score report has to say about Amedisys Inc.
2019-05-30 05:36:09 | Is Trade War Scaring You? Buy 5 DuPont-Tested Quality Stocks
2019-05-29 13:01:44 | Amedisys to Present at the William Blair 2019 Growth Stock Conference
2019-05-22 15:06:41 | Amedisys to Present at the Jefferies 2019 Healthcare Conference
2019-05-21 09:26:18 | See what the IHS Markit Score report has to say about Amedisys Inc.
2019-05-15 08:45:12 | Here is Why Growth Investors Should Buy Amedisys AMED Now
2019-05-15 08:33:46 | Do Directors Own Amedisys, Inc. NASDAQ:AMED Shares?
2019-05-14 12:06:35 | Amedisys to Present at the 2019 RBC Capital Markets Healthcare Conference
2019-05-14 11:45:43 | See what the IHS Markit Score report has to say about Amedisys Inc.
2019-05-08 16:49:17 | Media Statement from Amedisys Commending the Home Health Payment Innovation Act of 2019
2019-05-08 12:02:27 | Amedisys to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference
2019-05-08 07:33:11 | 5 Stocks With Upgraded Broker Ratings Worth Betting on Now
2019-05-07 08:02:54 | See what the IHS Markit Score report has to say about Amedisys Inc.
2019-05-06 16:30:00 | Amedisys Celebrates More Than 7,000 Nurses During National Nurses Week
2019-05-02 08:54:12 | Amedisys AMED Tops Earnings and Revenue Estimates in Q1
2019-05-01 18:32:43 | AMEDISYS Inc AMED Q1 2019 Earnings Call Transcript
2019-05-01 17:17:09 | Edited Transcript of AMED earnings conference call or presentation 1-May-19 3:00pm GMT
2019-05-01 09:00:01 | Amedisys AMED Upgraded to Buy: Here's What You Should Know
2019-05-01 09:00:00 | Amedisys, Inc. to Host Earnings Call
2019-05-01 08:35:49 | One Thing To Remember About The Amedisys, Inc. NASDAQ:AMED Share Price
2019-04-30 17:13:33 | Amedisys: 1Q Earnings Snapshot
2019-04-30 16:30:00 | Amedisys Reports First Quarter 2019 Financial Results and Reaffirms 2019 Guidance
2019-04-29 13:40:05 | Zacks.com featured highlights include: Raytheon, Otter, Amedysis, Tutor and DMC
2019-04-29 08:45:12 | Amedisys AMED is an Incredible Growth Stock: 3 Reasons Why
2019-04-26 11:39:43 | Here’s What Hedge Funds Think About Amedisys Inc AMED
2019-04-26 08:50:12 | Buy These 5 Low Leverage Stocks to Avoid Huge Losses
2019-04-24 09:43:01 | These 5 Stocks Boast Impressive Interest Coverage Ratio
2019-04-23 10:32:02 | Amedisys AMED Reports Next Week: Wall Street Expects Earnings Growth
2019-04-22 08:28:12 | Edwards Lifesciences Takes Over CAS Medical Systems for $100M
2019-04-18 09:25:01 | Here's Why You Should Invest in Chemed CHE Stock Right Now
2019-04-17 08:32:09 | A Look At The Fair Value Of Amedisys, Inc. NASDAQ:AMED
2019-04-17 08:18:12 | Medidata Launches Acorn Artificial Intelligence Company
2019-04-16 10:49:02 | Hologic's Diagnostics Grows Strong, Escalating Costs a Woe